Logo image of SVS.MI

SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

BIT:SVS - Euronext Milan - IT0005469264 - Common Stock - Currency: EUR

7.4  -0.1 (-1.33%)

Fundamental Rating

6

Overall SVS gets a fundamental rating of 6 out of 10. We evaluated SVS against 60 industry peers in the Health Care Equipment & Supplies industry. SVS has only an average score on both its financial health and profitability. SVS may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SVS had positive earnings in the past year.
SVS had a positive operating cash flow in the past year.
In the past 5 years SVS has always been profitable.
SVS had a positive operating cash flow in each of the past 5 years.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

With a Return On Assets value of 3.44%, SVS perfoms like the industry average, outperforming 56.60% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.25%, SVS is in the better half of the industry, outperforming 73.58% of the companies in the same industry.
The Return On Invested Capital of SVS (7.57%) is better than 75.47% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SVS is in line with the industry average of 7.96%.
The 3 year average ROIC (6.10%) for SVS is below the current ROIC(7.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROIC 7.57%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

SVS has a Profit Margin (4.49%) which is in line with its industry peers.
SVS's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 8.07%, SVS perfoms like the industry average, outperforming 56.60% of the companies in the same industry.
In the last couple of years the Operating Margin of SVS has grown nicely.
With a Gross Margin value of 25.79%, SVS is not doing good in the industry: 86.79% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SVS has declined.
Industry RankSector Rank
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30

4

2. Health

2.1 Basic Checks

SVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SVS has been reduced compared to 1 year ago.
Compared to 5 years ago, SVS has less shares outstanding
SVS has a worse debt/assets ratio than last year.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 1.86 indicates that SVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.86, SVS is in line with its industry, outperforming 50.94% of the companies in the same industry.
The Debt to FCF ratio of SVS is 1705.18, which is on the high side as it means it would take SVS, 1705.18 years of fcf income to pay off all of its debts.
SVS's Debt to FCF ratio of 1705.18 is in line compared to the rest of the industry. SVS outperforms 45.28% of its industry peers.
A Debt/Equity ratio of 0.64 indicates that SVS is somewhat dependend on debt financing.
SVS has a Debt to Equity ratio of 0.64. This is in the lower half of the industry: SVS underperforms 71.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1705.18
Altman-Z 1.86
ROIC/WACC1.19
WACC6.36%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

SVS has a Current Ratio of 1.96. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SVS (1.96) is comparable to the rest of the industry.
SVS has a Quick Ratio of 1.42. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
SVS's Quick ratio of 1.42 is fine compared to the rest of the industry. SVS outperforms 69.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.42
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.52% over the past year.
Measured over the past years, SVS shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.81% on average per year.
SVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.19%.
Measured over the past years, SVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.34% on average per year.
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.51%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%

3.2 Future

Based on estimates for the next years, SVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.11% on average per year.
SVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.56% yearly.
EPS Next Y22.99%
EPS Next 2Y24.11%
EPS Next 3Y19.11%
EPS Next 5YN/A
Revenue Next Year5.76%
Revenue Next 2Y7.47%
Revenue Next 3Y6.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.25, which indicates a rather cheap valuation of SVS.
SVS's Price/Earnings ratio is rather cheap when compared to the industry. SVS is cheaper than 96.23% of the companies in the same industry.
SVS is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 5.47, which indicates a rather cheap valuation of SVS.
Based on the Price/Forward Earnings ratio, SVS is valued cheaper than 92.45% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SVS to the average of the S&P500 Index (22.10), we can say SVS is valued rather cheaply.
Industry RankSector Rank
PE 7.25
Fwd PE 5.47
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SVS is valued cheaper than 96.23% of the companies in the same industry.
SVS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 1112.48
EV/EBITDA 3.62
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SVS has a very decent profitability rating, which may justify a higher PE ratio.
SVS's earnings are expected to grow with 19.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)0.32
EPS Next 2Y24.11%
EPS Next 3Y19.11%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.82%, SVS has a reasonable but not impressive dividend return.
SVS's Dividend Yield is rather good when compared to the industry average which is at 2.26. SVS pays more dividend than 96.23% of the companies in the same industry.
SVS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 3.82%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y24.11%
EPS Next 3Y19.11%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

SVAS BIOSANA SPA

BIT:SVS (3/7/2025, 7:00:00 PM)

7.4

-0.1 (-1.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.88%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap41.44M
Analysts80
Price Target12.65 (70.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.82%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.68%
PT rev (3m)-12.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.46%
EPS NY rev (3m)-4.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 7.25
Fwd PE 5.47
P/S 0.34
P/FCF 1112.48
P/OCF 6.77
P/B 0.7
P/tB 0.88
EV/EBITDA 3.62
EPS(TTM)1.02
EY13.78%
EPS(NY)1.35
Fwd EY18.29%
FCF(TTM)0.01
FCFY0.09%
OCF(TTM)1.09
OCFY14.78%
SpS21.7
BVpS10.52
TBVpS8.44
PEG (NY)0.32
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROCE 9.95%
ROIC 7.57%
ROICexc 11.41%
ROICexgc 13.88%
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
FCFM 0.03%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
ROICexc(3y)9.61%
ROICexc(5y)8.9%
ROICexgc(3y)11.85%
ROICexgc(5y)10.85%
ROCE(3y)8.02%
ROCE(5y)10.69%
ROICexcg growth 3Y15.29%
ROICexcg growth 5Y7.17%
ROICexc growth 3Y14.84%
ROICexc growth 5Y6.65%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1705.18
Debt/EBITDA 2.51
Cap/Depr 118.33%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 40.95%
Profit Quality 0.68%
Current Ratio 1.96
Quick Ratio 1.42
Altman-Z 1.86
F-Score8
WACC6.36%
ROIC/WACC1.19
Cap/Depr(3y)116.12%
Cap/Depr(5y)115.75%
Cap/Sales(3y)5.74%
Cap/Sales(5y)5.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.51%
EPS Next Y22.99%
EPS Next 2Y24.11%
EPS Next 3Y19.11%
EPS Next 5YN/A
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%
Revenue Next Year5.76%
Revenue Next 2Y7.47%
Revenue Next 3Y6.56%
Revenue Next 5YN/A
EBIT growth 1Y24.73%
EBIT growth 3Y21.21%
EBIT growth 5Y14.92%
EBIT Next Year90.97%
EBIT Next 3Y28.96%
EBIT Next 5YN/A
FCF growth 1Y100.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y212.56%
OCF growth 3Y9.06%
OCF growth 5Y6.2%